Results 81 to 90 of about 10,542 (115)

Long-Term Response and Survival in Extensive-Stage SCLC Receiving Atezolizumab Plus Chemotherapy in a Real-World Setting: IFCT-1905 CLINATEZO. [PDF]

JTO Clin Res Rep
Falchero L, Amrane K, Godbert B, Leterre B, Madelaine J, Fournel P, Mascaux C, Raimbourg J, Schneider S, Swalduz A, Veillon R, Langlais A, Missy P, Morin F, Westeel V, Girard N.   +15 more
europepmc   +1 more source

BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer. [PDF]

Breast
Guinel T, Lusque A, Mailliez A, Massard V, Jacot W, Guiu S, de la Motte Rouge T, Brain E, Desmoulins I, Arnedos M, Bailleux C, Goncalves A, Levy C, Bachelot T, Bosquet L, Delaloge S, Frénel JS.   +16 more
europepmc   +1 more source

Prospective pilot study with [⁸⁹Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE). [PDF]

Eur J Nucl Med Mol Imaging
Rousseau C, Heyman MF, Ferrer L, Rauscher A, Morel A, Rusu D, Frenel JS, Taupin M, Vilcot L, Allam N, Robert M, Campone M, Campion L, Kraeber-Bodéré F.   +13 more
europepmc   +1 more source

Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus study. [PDF]

Clin Transl Radiat Oncol
Thariat J, Beddok A, Salas S, Gorphe P, Doré M, Racadot S, Vozy A, Pointreau Y, Dupin C, Renard S, Mouawad F, Pereira S, Deneuve S, Blanchard P.   +13 more
europepmc   +1 more source

Development and Assessment of a Pipeline for Extracting Structured Data From Free-Text Medical Reports Using a Large Language Model. [PDF]

JCO Clin Cancer Inform
Joseph E, Vallee P, Perennec T, Wagneur N, Frenel JS, Campone M, Bocquet F, Le Borgne F.   +7 more
europepmc   +1 more source

Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results. [PDF]

Tech Innov Patient Support Radiat Oncol
Ayadi M, Dupuis P, Sandt M, Beldjoudi G, Serre A, Martel-Lafay I, Claude L, Guimas V, Chiavassa S, Moignier A, Alexis A, Ollivier L, Vaugier L, Lange M, Moncharmont C, Sunyach MP.   +15 more
europepmc   +1 more source

Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61-FUNGEMAX trial (France). [PDF]

EClinicalMedicine
Taieb J, Pernot S, Thuillier F, Delattre A, Vo-Quang E, Petorin C, Bourgeois V, Tougeron D, Audemar F, Vitellius C, Mosser L, Desrame J, Di Fiore F, Rinaldi Y, Pellat A, Bolliet M, Watelle F, Perrier H, Dubreuil O, Lepage C, Bachet JB.   +20 more
europepmc   +1 more source

Benign-Appearing Palmar Lesion in a Young Woman: The Importance of Considering Digital Papillary Adenocarcinoma. [PDF]

Cureus
Cannaferina E, Rouveyrol M, Michot A, Peuvrel L, Ardouin L.   +4 more
europepmc   +1 more source

Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne^® Liquid CDx. [PDF]

Cancers (Basel)
Chibaudel B, Carola E, Mekranter H, Goyer P, Saget A, Oberlin O, Marijon H, Richa H, Iurisci I, Gervais H, Perez-Staub N, Dainese L, Pujol P, Lamallem H, Besnard C, Latrache S, Toledano A, de Gramont A.   +17 more
europepmc   +1 more source

Dosimetric Feasibility of Dose-Painting Radiation Therapy for Targeting Hypoxia in Prostate Cancer on a Novel Ring Gantry Radiation Therapy System. [PDF]

Adv Radiat Oncol
Perennec T, Al Feghali KA, de Jong D, Oderinde OM, Gibbard G, Dore M, Delpon G, Alexandra M, Seroux Y, Ferrer L, Hatt M, Rousseau C, Supiot S.   +12 more
europepmc   +1 more source